Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Innovation1 Biotech Inc IVBT

Innovation1 Biotech Inc. is a shell company. The Company has no operations and is evaluating a number of strategic alternatives including, but not limited to, seeking to acquire a new business in the United States, including potentially by means of a reverse merger with an operating entity. The Company has no sources of revenue.

GREY:IVBT - Post Discussion

Innovation1 Biotech Inc > Amazing product
View:
Post by robthoma on Mar 08, 2018 11:46am

Amazing product

Bought in today at .66
Comment by robthoma on Mar 08, 2018 1:06pm
      inShare Share this Page:    ...more  
Comment by robthoma on Mar 08, 2018 10:51pm
Gridiron BioNutrients™ Introduces its new Alkaline CBD Water "Gridiron CBD H2O Probiotics™" Endorsed by the National Football League Alumni (NFLA) Under its Pro Football Legends Commercial Marketing Arm.   NEWS PROVIDED BY Gridiron BioNutrients, Inc.  Dec 07, 2017, 09:27 ET SHARE THIS ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities